PATENT CLAIM ANALYSIS

Application Number: 16355352
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-09
Patent Classification: ["514", "263200"]

Abstract:
The invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof wherein A, X, R 1 , R 4  and n are as defined herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.

Claim (Index 6):
The compound of  claim 3 , wherein each R 2  is independently; H; \u2014CH 3 ; \u2014CN; -halo; \u2014NH 2 ; \u2014NHCH 3 ; NHCH 2 CH 3 ; \u2014NHCH 2 CH 2 CH 2 OH; \u2014NHCH 2 CH 2 OCH 3 ; \u2014NHC(O)CH 3 ; \u2014NHCH 2 C(O)N(CH 3 ) 2 ; and p is 0 or 1.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 99.0
- Lexical Diversity: 1.56
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14118113', '16033632', '15298686', '15459141', '15945852']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8082529889073605
- 35 USC 102 Novelty (BERT): 0.5201316372888313
- Combined Prediction Score: 0.7794408537455075
- Mean Citation Score: 320.109122
- Max Citation Score: 323.93375
- Similarity Product: 249.81977435290813

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test